Biopharmaceutical Tubing Market Size and CAGR by 2031
The biopharmaceutical tubing market size is projected to reach US$ 7.64 billion by 2031 from US$ 4.04 billion in 2023. The market is expected to register a CAGR of 8.30% during 2023–2031. Platinum-cured silicone as the material of choice for biopharmaceutical tubing will likely remain a key trend in the market.
Biopharmaceutical Tubing Market Analysis
Biopharmaceutical tubing is a well-established market. However, because there is an increasing focus on better surgical procedure outcomes and related conditions, it is predicted to grow more quickly. The main factors driving the market's expansion are the rising number of minimally invasive procedures and the sharply increasing demand for medical devices that use tubing in the area.
According to estimates, the biopharmaceutical tubing market is expected to grow fastest in Asia. The aging population, pharmaceuticals, and the availability of reasonably priced medical-grade plastics will significantly enhance prospects for profit.
Biopharmaceutical Tubing Market Overview
An increase in life expectancy is contributing to the global geriatric population. The World Health Organization (WHO) projects that by 2050, the proportion of adults over 60 worldwide will almost double, from 12% in 2015 to 22%. The World Population Ageing 2017 report from the United Nations states that there were 962 million adults in the world in 2017 who were 60 or older. That figure is projected to rise to approximately 2.1 billion by 2050. Furthermore, the US Census Bureau projects that the population of Americans 65 and older will increase from 46 million in 2016 to over 98 million by 2060, increasing their population share from approximately 15% to approximately 24% during this time. Europe has the most significant proportion of adults over 60 (25%), according to the United Nations World Population Ageing 2017 report. A considerable portion of the population in every region of the world, except Africa, will be 60 or older by 2050 due to the acceleration of global aging. By 2030, 2050, and 2100, respectively, the global geriatric population is projected to amount to US$ 1.4 billion, US$ 2.1 billion, and more than US$ 3.1 billion. The aging population is causing a rise in geriatric illnesses, which in turn is driving up demand for medication delivery systems and diagnostic tools.
Additionally, it is contributing to the rise in the prevalence of urological disorders that need to be catheterized. In addition, doctors are pushing for self-catheterization to lower hospital stays and costs while lowering the risk of infections linked to healthcare (HAI). A critical contributing factor to the rise in chronic illnesses that may necessitate interventions involving ICU admission is aging. The adoption of biopharmaceutical tubing systems is thus driven by the rapid growth in the geriatric population, which is directly correlated with the growing demand for medical devices that incorporate tubing, drug delivery, dialysis, cardiac bypass, peristaltic pump, and sterile filling and dispensing systems.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Tubing Market: Strategic Insights
Market Size Value in US$ 3,442.82 Million in 2021 Market Size Value by US$ 6,013.27 Million by 2028 Growth rate CAGR of 8.3% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Tubing Market: Strategic Insights
| Market Size Value in | US$ 3,442.82 Million in 2021 |
| Market Size Value by | US$ 6,013.27 Million by 2028 |
| Growth rate | CAGR of 8.3% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Biopharmaceutical Tubing Market Drivers and Opportunities
Rising Demand for Minimally Invasive Procedures Favors Market Growth
A tiny device or an implant is typically inserted into the body through an incision or other anatomical opening during a minimally invasive medical procedure. These procedures have become increasingly popular because they involve small incisions, patients recover more quickly, and patients experience less discomfort. Additionally, these operations are linked to advantages like reduced pain, minimal tissue damage, and less trauma to the muscles, nerves, tissues, and organs.
The need for less invasive procedures has increased due to the rising incidence of cancer, heart disease, and arthritis, all of which need lengthy surgical treatments. Catheters and biopharmaceutical tubing, among other components, are in high demand. Biopharmaceutical tubing systems also help with time-saving procedures and are reasonably priced. For instance, the time needed for the medical or surgical procedure is significantly reduced when catheter tubing is used for cardiac and urine catheterization. Thus, the increasing need for less invasive medical procedures and the emphasis on making these procedures more efficient are significant factors driving the market for biopharmaceutical tubing.
Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries Creates Significant Opportunities in the Market
Chronic disease prevalence is on the rise in developing nations as a result of significant, gradual changes in lifestyle. Moreover, the prevalence of other health conditions, such as occupational disorders, is rising due to the adoption of modern work cultures and infrastructure. Modern facilities cause their occupants to engage in less physical activity, but the intense competition in the market also contributes to increased stress levels. Thus, the need for catheters and biopharmaceutical tubing will rise in these economies as the prevalence of chronic diseases increases and more people seek medical attention. The economies of Brazil, India, Russia, China, and South Africa (BRICS) are some of the fastest-growing in the world. The aging population, changes in customer demand, and increased awareness of healthcare services are all expected to contribute to the projected rapid expansion of the healthcare sectors in these and other developing economies shortly. The biopharmaceutical tubing market is expected to have substantial potential in the upcoming years due to the growth of this industry. The development of the healthcare sector and the biopharmaceutical tubing market is also anticipated to be aided by higher government spending on healthcare facilities and rising consumer purchasing power.
Biopharmaceutical Tubing Market Report Segmentation Analysis
Key segments that contributed to the derivation of the biopharmaceutical tubing market analysis are type and application.
- Based on type, the biopharmaceutical tubing market is divided into plastic, metal, and silicone. The silicone segment held the most significant market share in 2023.
- By application, the market is categorized into pharmaceutical {single use technology and others, research and development, medical devices, and others. The pharmaceutical segment held the largest share of the market in 2023.
Biopharmaceutical Tubing Market Share Analysis by Geography
The geographic scope of the biopharmaceutical tubing market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America consists of three countries: the US, Canada, and Mexico. The US held the largest share of the rising demand for medical devices that incorporate tubing. The adoption of advanced medical devices, technological advancements, and a shift toward minimally invasive medical procedures are projected to accelerate the growth of the biopharmaceutical tubing market. Moreover, Market players are adopting organic and inorganic growth strategies for market development. For instance, In November 2019, Saint-Gobain Life Sciences completed construction on its new plant in Largo, Florida, marking another key milestone in its €70 million worldwide expansion initiative, which will see seven production locations built and operational by the end of 2020. The 80,000 SF Largo, FL, facility will become an additional manufacturing site for Saint-Gobain’s C-Flex tubing, molded connections, and assemblies used in fluid management for biopharmaceutical manufacturing. Saint-Gobain will continue to produce C-Flexs tubing and related product lines at its existing facilities in Clearwater, FL; Charny, France; and Bangalore, India.
Similarly, in March 2017, AdvantaPure launched the AdvantaSil brand of silicone tubing and hose. AdvantaSil silicone tubing and hose products are for single-use processes, from the reinforced hose, unreinforced tubing wire reinforced suction hose, and pump grade tubing. The products are designed and tested for the pharmaceutical and biopharmaceutical industries.
Thus, owing to the factors mentioned above, the biopharmaceutical tubing market is anticipated to grow in the coming years in the country
Biopharmaceutical Tubing Market Report Scope
Biopharmaceutical Tubing Market News and Recent Developments
The biopharmaceutical tubing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the biopharmaceutical tubing market are listed below:
- DuPont is accelerating its investments for the future of the biopharmaceutical processing industry by expanding its supply capacity of silicone elastomers and tubing and by enlarging its single-use pharma product lines with new thermoplastic elastomer (TPE) tubing (Source: DuPont, Press Release, April 2022)
- Optinova opened its Optinova Valley Forge plant. The new factory is an investment to significantly increase production capacity for specialty industrial tubing solutions. Optinova Valley Forge can house over 20 extrusion lines at maximum capacity and have 11 extrusion lines up. (Source: Optinova, Press Release, May 2021)
Biopharmaceutical Tubing Market Report Coverage and Deliverables
The “Biopharmaceutical Tubing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Biopharmaceutical tubing market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Biopharmaceutical tubing market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Biopharmaceutical tubing market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the biopharmaceutical tubing market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The market is expected to register a CAGR of 8.30% during 2023–2031.
W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG
Key factors driving the market are the increasing elderly population worldwide and the rising demand for minimally invasive procedures.
Platinum-cured silicone as the material of choice for biopharmaceutical tubing will likely remain a key trend in the market.
North America dominated the biopharmaceutical tubing market in 2023
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For